Compounds > beta-alanine

beta-alanine and thromboplastin

beta-alanine has been researched along with thromboplastin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castellino, FJ; Fernández, JA; Furlan-Freguia, C; Griffin, JH; Mosnier, LO; Niessen, F; Rosen, H; Ruf, W; Weiler, H1
Christersson, C; Johnell, M; Siegbahn, A1
Gong, GQ; He, GW; Jiang, ML; Li, YZ; Wang, XH; Xu, YG; Yang, WH; Yang, XZ; Zhou, Y1
Hosokawa, K; Koide, T; Maruyama, I; Miura, N; Ohnishi, T; Sameshima, H; Tanaka, KA1
Boyle, ME; Fisher, S; Ishimoto, J; Kiser, TH; Lind, SE; Trujillo, TC1
Ammollo, CT; Colucci, M; Semeraro, N; Testa, S; Visino, F; Zaccaria, F1

Other Studies

6 other study(ies) available for beta-alanine and thromboplastin

ArticleYear
Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality.
    Blood, 2009, Mar-19, Volume: 113, Issue:12

    Topics: Animals; beta-Alanine; Capillary Leak Syndrome; Capillary Permeability; Disseminated Intravascular Coagulation; Endothelial Protein C Receptor; Endothelium, Vascular; Endotoxins; Enzyme Activation; Glycoproteins; Hirudins; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Protein C; Receptor, PAR-1; Receptors, Cell Surface; Receptors, Lysosphingolipid; Signal Transduction; Specific Pathogen-Free Organisms; Sphingosine-1-Phosphate Receptors; Systemic Inflammatory Response Syndrome; Thiophenes; Thrombin; Thromboplastin

2009
The influence of direct thrombin inhibitors on the formation of platelet-leukocyte aggregates and tissue factor expression.
    Thrombosis research, 2010, Volume: 126, Issue:4

    Topics: Antithrombins; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Blood Platelets; Cell-Derived Microparticles; Dabigatran; Gene Expression; Humans; Leukocytes; Myocardial Infarction; Platelet Activation; Platelet Aggregation; RNA, Messenger; Thromboplastin

2010
Antithrombotic activity of HY023016, a novel Dabigatran prodrug evaluated in animal thrombosis models.
    Thrombosis research, 2013, Volume: 131, Issue:5

    Topics: Animals; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Disease Models, Animal; Mice; Prodrugs; Rabbits; Rats; RNA, Messenger; Thrombin; Thromboplastin; Thrombosis

2013
Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Adenosine Triphosphate; Adult; Anticoagulants; Antithrombins; Aspirin; Benzimidazoles; beta-Alanine; Blood Platelets; Dabigatran; Dose-Response Relationship, Drug; Factor Xa; Factor Xa Inhibitors; Female; Fibrin; Humans; Lab-On-A-Chip Devices; Male; Microscopy, Confocal; Morpholines; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Rivaroxaban; Thiophenes; Thrombin; Thromboplastin; Thrombosis

2014
Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples.
    American journal of clinical pathology, 2014, Volume: 141, Issue:5

    Topics: Antithrombins; Arginine; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Drug Monitoring; Heparin; Hirudins; Humans; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin; Thrombin Time; Thromboplastin

2014
Influence of cell-associated tissue factor concentration on the anticoagulant activity of dabigatran. A possible explanation for the reduced incidence of intracranial bleeding.
    British journal of haematology, 2015, Volume: 168, Issue:6

    Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Case-Control Studies; Cerebral Hemorrhage; Dabigatran; Humans; Thromboplastin; Warfarin

2015